Title 21

PART 207 SUBPART D

21 U.S.C. 321, 331, 351, 352, 355, 360, 360b, 371, 374, 381, 393; 42 U.S.C. 262, 264, 271.
81 FR 60212, Aug. 31, 2016, unless otherwise noted.

21:4.0.1.1.7.4.1.1	SECTION 207.41	207.41 Who must list drugs and what drugs must they list
21:4.0.1.1.7.4.1.2	SECTION 207.45	207.45 When, after initial registration of an establishment, must drug listing information be submitted
21:4.0.1.1.7.4.1.3	SECTION 207.49	207.49 What listing information must a registrant submit for a drug it manufactures
21:4.0.1.1.7.4.1.4	SECTION 207.53	207.53 What listing information must a registrant submit for a drug that it repacks or relabels
21:4.0.1.1.7.4.1.5	SECTION 207.54	207.54 What listing information must a registrant submit for a drug that it salvages
21:4.0.1.1.7.4.1.6	SECTION 207.55	207.55 What additional drug listing information may FDA require
21:4.0.1.1.7.4.1.7	SECTION 207.57	207.57 What information must registrants submit when updating listing information and when